Your browser doesn't support javascript.
loading
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study.
Versluis, Jurjen; Saber, Wael; Tsai, Harrison K; Gibson, Christopher J; Dillon, Laura W; Mishra, Asmita; McGuirk, Joseph; Maziarz, Richard T; Westervelt, Peter; Hegde, Pranay; Mukherjee, Devdeep; Martens, Michael J; Logan, Brent; Horowitz, Mary; Hourigan, Christopher S; Nakamura, Ryotaro; Cutler, Corey; Lindsley, R Coleman.
Afiliação
  • Versluis J; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Saber W; Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands.
  • Tsai HK; Medical College of Wisconsin, Milwaukee, WI.
  • Gibson CJ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Dillon LW; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Mishra A; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • McGuirk J; Moffitt Cancer Center, Tampa, FL.
  • Maziarz RT; University of Kansas Cancer Center, Kansas City, KS.
  • Westervelt P; Oregon Health and Science University, Portland, OR.
  • Hegde P; Washington University in Saint Louis, Saint Louis, MO.
  • Mukherjee D; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Martens MJ; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Logan B; Medical College of Wisconsin, Milwaukee, WI.
  • Horowitz M; Medical College of Wisconsin, Milwaukee, WI.
  • Hourigan CS; Medical College of Wisconsin, Milwaukee, WI.
  • Nakamura R; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Cutler C; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD.
  • Lindsley RC; City of Hope National Medical Center, Duarte, CA.
J Clin Oncol ; 41(28): 4497-4510, 2023 Oct 01.
Article em En | MEDLINE | ID: mdl-37607457
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Marrocos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Marrocos